These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3675609)

  • 21. Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
    Murray D; Meyn RE
    Br J Cancer; 1984 Dec; 50(6):801-8. PubMed ID: 6498077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misonidazole binding in SCCVII tumors in relation to the tumor blood supply.
    Olive PL; Durand RE
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):755-61. PubMed ID: 2921174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution of 14C-misonidazole as a probe for hypoxic cells in a murine tumor model.
    Ikeda H; Takahashi I; Yonome I; Mitsuhashi N; Niibe H
    Anticancer Res; 1998; 18(1A):241-5. PubMed ID: 9568084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 3H-misonidazole binding between CHO and 9L cells using the sandwich system.
    Hlatky L; Ring C; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):943-7. PubMed ID: 2703402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention.
    Baumgardner KR; Walton RE; Osborne JW; Born JL
    J Dent Res; 1996 Oct; 75(10):1753-60. PubMed ID: 8955670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misonidazole retention by normal tissues: a distinction between label on the ring and side chain.
    Franko AJ; Garrecht BM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1259-62. PubMed ID: 3744949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.
    MacManus MP; Maxwell AP; Abram WP; Bridges JM
    Br J Cancer; 1989 Mar; 59(3):349-52. PubMed ID: 2930698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro.
    Franko AJ; Koch CJ; Garrecht BM; Sharplin J; Hughes D
    Cancer Res; 1987 Oct; 47(20):5367-76. PubMed ID: 3652041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA damage in normal and neoplastic mouse tissues after treatment with misonidazole in vivo.
    Murray D; Meyn RE
    Biochem Pharmacol; 1985 Sep; 34(18):3275-9. PubMed ID: 4038336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced misonidazole binding in the presence of AF-2.
    Olive PL
    Radiat Res; 1987 Mar; 109(3):490-9. PubMed ID: 3562787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding.
    Kim IH; Lemmon MJ; Brown JM
    Radiat Res; 1993 Sep; 135(3):411-7. PubMed ID: 8378534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel technique for measuring human tissue pO2 at the cellular level.
    Urtasun RC; Koch CJ; Franko AJ; Raleigh JA; Chapman JD
    Br J Cancer; 1986 Sep; 54(3):453-7. PubMed ID: 3756081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole.
    Cobb LM; Hacker T; Nolan J
    Br J Cancer; 1990 Apr; 61(4):524-9. PubMed ID: 2331439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.